首页> 美国卫生研究院文献>Journal of Korean Medical Science >Protective Effects of Gabapentin on Allodynia and α2δ1-Subunit of Voltage-dependent Calcium Channel in Spinal Nerve-Ligated Rats
【2h】

Protective Effects of Gabapentin on Allodynia and α2δ1-Subunit of Voltage-dependent Calcium Channel in Spinal Nerve-Ligated Rats

机译:加巴喷丁对脊髓神经结扎大鼠痛觉异常和电压依赖性钙通道α2δ1-亚基的保护作用

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。
获取外文期刊封面目录资料

摘要

This study was designed to determine whether early gabapentin treatment has a protective analgesic effect on neuropathic pain and compared its effect to the late treatment in a rat neuropathic model, and as the potential mechanism of protective action, the α2δ1-subunit of the voltage-dependent calcium channel (α2δ1-subunit) was evaluated in both sides of the L5 dorsal root ganglia (DRG). Neuropathic pain was induced in male Sprague-Dawley rats by a surgical ligation of left L5 nerve. For the early treatment group, rats were injected with gabapentin (100 mg/kg) intraperitoneally 15 min prior to surgery and then every 24 hr during postoperative day (POD) 1-4. For the late treatment group, the same dose of gabapentin was injected every 24 hr during POD 8-12. For the control group, L5 nerve was ligated but no gabapentin was administered. In the early treatment group, the development of allodynia was delayed up to POD 10, whereas allodynia was developed on POD 2 in the control and the late treatment group (p<0.05). The α2δ1-subunit was up-regulated in all groups, however, there was no difference in the level of the α2δ1-subunit among the three groups. These results suggest that early treatment with gabapentin offers some protection against neuropathic pain but it is unlikely that this action is mediated through modulation of the α2δ1-subunit in DRG.
机译:这项研究旨在确定加巴喷丁的早期治疗是否对神经性疼痛具有保护性镇痛作用,并将其与大鼠神经性模型中的晚期治疗进行比较,并将其作为保护作用的潜在机制,即电压依赖性α2δ1-亚基在L5背根神经节(DRG)的两侧评估钙通道(α2δ1-亚基)。通过手术结扎左L5神经在雄性Sprague-Dawley大鼠中诱发神经性疼痛。对于早期治疗组,大鼠在手术前15分钟腹膜内注射加巴喷丁(100 mg / kg),然后在术后第1-4天(POD)每24小时注射一次。对于晚期治疗组,在POD 8-12期间每24小时注射相同剂量的加巴喷丁。对于对照组,结扎L5神经,但不施用加巴喷丁。在早期治疗组中,异常疼痛的发展延迟至POD 10,而对照组和晚期治疗组中的异常疼痛发生在POD 2上(p <0.05)。所有组中的α2δ1-亚基都被上调,但是,三组中α2δ1-亚基的水平没有差异。这些结果表明,加巴喷丁的早期治疗可提供针对神经性疼痛的某些保护作用,但这种作用不太可能通过调节DRG中的α2δ1-亚基来介导。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号